Diabetes Management Market - (By Technology- Glucose Test Strips, Digital Health / Digital Therapeutics, Insulin Pumps, Continuous Glucose Monitoring (CGM), Insulin Pens, Side Effect Management And Diagnosis) - Global Industry Size, Share, Trends, and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 180

Introduction

Diabetes is a metabolic disease in which the blood sugar levels of the body is increased for extended period. During last few years, there is significant increase in the prevalence of the diabetes which has led to increase in the demand for the various types of technology for diabetes. This technology includes glucose test strips, digital health / digital therapeutics, insulin pumps, continuous glucose monitoring (CGM), insulin pens, side effect management and diagnosis. Digitalization and development in the technology has led to the introduction of the advanced devices. A number of companies are involved in the development of the advanced devices which are used in the management of the diabetes.

 Market Dynamics

During last decade there is a significant increase in the prevalence of the diabetes. As per the WHO, approximately 422 million people across the globe were suffering from diabetes in 2014 which is expected to increase in near future. Increasing prevalence of the diabetes is the major driving factor for the growth of the market. Obese and smokers are more prone to diabetes. Increasing patient suffering from obesity and changing lifestyle of the people has catalyzed the growth of the technology for diabetes management market. Moreover, increased the demand for the better treatment option, increasing per capita income, increasing government support, increasing healthcare expenditure, and development in the technology have boosted the growth of the market during the forecast period 2018—2026. However, lack of awakes among the people and limited availability of the skilled professionals are responsible for affecting the growth of the market negatively. In near future the market is expecting a healthy opportunity owing to the continuous increasing demand for the better technology.

Market Classification

The global technology for diabetes management market is majorly segmented into technology and region.

On the basis of technology, the market is segmented into glucose test strips, digital health / digital therapeutics, insulin pumps, continuous glucose monitoring (CGM), insulin pens, side effect management and diagnosis, and others.

Regional Overview

Regionally, the technology for diabetes management market is segmented into North America, Europe, Asia Pacific and Latin America, Middle East & Africa.

North America is expected to dominate the technology for diabetes management market owing to the presence of huge patient pool, advancement in technology, and high spending on healthcare. According to WHO, 9.2% of the American population were suffering from diabetes in 2015. Additionally, presence of a huge number of players and increasing government support will fuel the growth of the market. Europe accounts for the second leading market in the forecast period followed by the Asia Pacific. Presences of huge investment in European region, huge government support, and well developed economies have driven the growth of the European market.

Asia Pacific technology for diabetes management market expected to be the fastest growth during the forecast period of 2016—2026. The growth is majorly attributed due to presence of huge diabetic and obese patients of the region. According to the International Diabetes Federation (IDF), in 2016, approximately 60% of total global diabetic population was present in Asia of which over 114 million are in China alone. Moreover, increasing government support and increasing per capita income have fueled the growth of the Asia Pacific market. LAMEA region is expecting a steady growth during the forecast period 2018—2026.

Report Coverage

Market

Technology for Diabetes Management  Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

 Technology, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major key players in the market are Abbott, Animas, DexCom, Medtronic, Roche, Accu-Chek, Eli Lilly, Bayer, LifeScan, Novo Nordisk, Sanofi-aventis, Merck, Takeda Pharmaceuticals, Novartis, and Bristol-Myers Squibb.

Market Segmentation

Market By Technology

  • Glucose Test Strips
  • Digital Health / Digital Therapeutics
  • Insulin Pumps
  • Continuous Glucose Monitoring (CGM)
  • Insulin Pens
  • Side Effect Management & Diagnosis
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary